BETH PERRY: Open Payments
NPI 1891722872 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$491 in 12 payments from 8 companies in 2025. Trend: 2023 $349 · 2024 $334 · 2025 $491
Food & beverage: $491
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $205 |
| UCB, Inc. | 1 | $125 |
| Almirall LLC | 2 | $45 |
| GENZYME CORPORATION | 1 | $30 |
| Incyte Corporation | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Amgen Inc. | 1 | $20 |
| Galderma Laboratories, L.P. | 1 | $18 |
Products named: RINVOQ, Bimzelx, DUPIXENT, SKYRIZI, OPZELURA, Klisyri, COSENTYX, Seysara.
Industry payments across FL — which companies pay providers there.
